IAS-LAB PUBLICATIONS

Clear

Resorbable engineered barrier membranes for oral surgery applications

Authors: Balducci Cristian; Zamuner Annj; Todesco Martina; Bagno Andrea; Pasquato Antonella; Iucci Giovanna; Bertela Federica; Battocchio Chiara; Tortora Luca; Sacchetto Luca; Brun Paola; Bressan Eriberto; Dettin Monica; Bertelà Federica

Journal: JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Published: 2024

DOI: 10.1002/jbm.a.37752

Population aging, reduced economic capacity, and neglecting the treatments for oral pathologies, are the main causal factors for about 3 billion individuals who are suffering from partial/total edentulism or alveolar bone resorption: thus, the demand for dental implants is increasingly growing. To achieve a good prognosis for implant-supported restorations, adequate peri-implant bone volume is mandatory. The Guided Bone Regeneration (GBR) technique is one of the most applied methods for alveolar bone reconstruction and treatment of peri-implant bone deficiencies. This technique involves the use of different types of membranes in association with some bone substitutes (autologous, homologous, or heterologous). However, time for bone regeneration is often too long and the bone quality is not simply predictable. This study aims at engineering and evaluating the efficacy of modified barrier membranes, enhancing their bioactivity for improved alveolar bone tissue regeneration. We investigated membranes functionalized with chitosan (CS) and chitosan combined with the peptide GBMP1α (CS + GBMP1α), to improve bone growth. OsseoGuard® membranes, derived from bovine Achilles tendon type I collagen crosslinked with formaldehyde, were modified using CS and CS + GBMP1α. The functionalization, carried out with 1-ethyl-3-(3 dimethylaminopropyl)carbodiimide and sulfo-N-Hydroxysuccinimide (EDC/sulfo-NHS), was assessed through FT-IR and XPS analyses. Biological assays were performed by directly seeding human osteoblasts onto the materials to assess cell proliferation, mineralization, gene expression of Secreted Phosphoprotein 1 (SPP1) and Runt-Related Transcription Factor 2 (Runx2), and antibacterial properties. Both CS and CS + GBMP1α functionalizations significantly enhanced human osteoblast proliferation, mineralization, gene expression, and antibacterial activity compared to commercial membranes. The CS + GBMP1α functionalization exhibited superior outcomes in all biological assays. Mechanical tests showed no significant alterations of membrane biomechanical properties post-functionalization. The engineered membranes, especially those functionalized with CS + GBMP1α, are suitable for GBR applications thanks to their ability to enhance osteoblast activity and promote bone tissue regeneration. These findings suggest a potential advancement in the treatment of oral cavity problems requiring bone regeneration.

Volume: 112 Pages: 1960-1974

Keywords: BMP-2; chitosan; GBR membranes; human osteoblasts; peptide;

Eosinophilic esophagitis in adults and adolescents: epidemiology, diagnostic challenges, and management strategies for a type 2 inflammatory disease

Authors: Savarino Edoardo Vincenzo; Barbara Giovanni; Bilo Maria Beatrice; De Bortoli Nicola; Di Sabatino Antonio; Oliva Salvatore; Penagini Roberto; Racca Francesca; Tortora Annalisa; Rumi Filippo; Cicchetti Americo; Bilò Maria Beatrice

Journal: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

Published: 2024

DOI: 10.1177/17562848241249570

Background: Eosinophilic esophagitis (EoE) is recognized as a chronic type 2 inflammatory disease characterized by the eosinophilic infiltration of the esophageal tissue, posing a significant disease burden and highlighting the necessity for novel management strategies to address unmet clinical needs. Objectives: To critically evaluate the existing literature on the epidemiology and management of EoE, identify evidence gaps, and assess the efficacy of current and emerging treatment modalities. Design: An extensive literature review was conducted, focusing on the epidemiological trends, diagnostic challenges, and therapeutic interventions for EoE. This was complemented by a survey among physicians and consultations with a scientific expert panel, including a patient’s association (ESEO Italia), to enrich the study findings. Data sources and methods: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, scrutinizing epidemiological studies and management research to compile comprehensive insights into the disease’s landscape. The physician survey and expert panel discussions aimed to bridge identified evidence gaps. Results: The review included 59 epidemiological and 51 management studies, uncovering variable incidence and prevalence rates of EoE globally, with an estimated diagnosed prevalence of 41 per 100,000 in Italy. Diagnostic challenges were identified, including nonspecific symptoms and the lack of definitive biomarkers, which complicate the use of endoscopy. Treatment options such as elimination diets, proton-pump inhibitors, and swallowed corticosteroids were found to have varying success rates, while Dupilumab, an emerging therapy targeting interleukin (IL)-4 and IL-13, shows promise. Conclusion: Despite advancements in understanding and managing EoE, significant unmet clinical needs remain, particularly in biomarker identification, therapy personalization, and cost-effectiveness evaluation. A comprehensive, multidimensional approach to patient management is required, emphasizing the importance of early symptom recognition, accurate diagnosis, and tailored treatment strategies. Dupilumab offers potential as a novel treatment, underscoring the need for future research to explore the economic and social dimensions of EoE care pathways.

Volume: 17

Keywords: diagnosis; eosinophilic esophagitis; epidemiology; systematic review; treatment pathway;

VADER: Probing the Dark Side of Dimorphos with LICIACube LUKE

Authors: Zinzi Angelo; Hasselmann P. H. A.; Della Corte V.; Deshapriya J. D. P.; Gai I.; Lucchetti A.; Pajola A.; Rossi A.; Dotto E.; Epifani E. Mazzotta; Daly R. T.; Hirabayashi M.; Farnham T.; Ernst C. M.; Ivanovski S. L.; Li J. -y.; Parro L. M.; Amoroso M.; Beccarelli J.; Bertini I.; Brucato J. R.; Capannolo A.; Caporali S.; Ceresoli M.; Cremonese G.; Dall'Ora M.; Casajus L. Gomez; Gramigna E.; Ieva S.; Impresario G.; Manghi R. Lasagni; Lavagna M.; Lombardo M.; Modenini D.; Negri B.; Palumbo P.; Perna D.; Pirrotta S.; Poggiali G.; Tortora P.; Tusberti F.; Zannoni M.; Zanotti G.; Hasselmann P.H.A.; Deshapriya J.D.P.; Mazzotta Epifani E.; Daly R.T.; Ernst C.M.; Ivanovski S.L.; Li J.-Y.; Parro L.M.; Brucato J.R.; Dall’Ora M.; Gomez Casajus L.; Lasagni Manghi R.

Journal: PLANETARY SCIENCE JOURNAL

Published: 2024

DOI: 10.3847/PSJ/ad3826

The ASI cubesat LICIACube has been part of the first planetary defense mission DART, having among its scopes to complement the DRACO images to better constrain the Dimorphos shape. LICIACube had two different cameras, LEIA and LUKE, and to accomplish its goal, it exploited the unique possibility of acquiring images of the Dimorphos hemisphere not seen by DART from a vantage point of view, in both time and space. This work is indeed aimed at constraining the tridimensional shape of Dimorphos, starting from both LUKE images of the nonimpacted hemisphere of Dimorphos and the results obtained by DART looking at the impacted hemisphere. To this aim, we developed a semiautomatic Computer Vision algorithm, named VADER, able to identify objects of interest on the basis of physical characteristics, subsequently used as input to retrieve the shape of the ellipse projected in the LUKE images analyzed. Thanks to this shape, we then extracted information about the Dimorphos ellipsoid by applying a series of quantitative geometric considerations. Although the solution space coming from this analysis includes the triaxial ellipsoid found by using DART images, we cannot discard the possibility that Dimorphos has a more elongated shape, more similar to what is expected from previous theories and observations. The result of our work seems therefore to emphasize the unique value of the LICIACube mission and its images, making even clearer the need of having different points of view to accurately define the shape of an asteroid.

Volume: 5

Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial

Authors: Pompili Enrico; Baldassarre Maurizio; Iannone Giulia; Tedesco Greta; Nardelli Silvia; Piano Salvatore; Alessandria Carlo; Neri Sergio; Foschi Francesco G.; Levantesi Fabio; Caraceni Paolo; Bernardi Mauro; Zaccherini Giacomo

Journal: LIVER INTERNATIONAL

Published: 2024

DOI: 10.1111/liv.16020

Type-2 diabetes mellitus is a frequent comorbidity of cirrhosis independently associated with cirrhosis-related complications and mortality. This post hoc analysis of the ANSWER trial database assessed the effects of long-term human albumin (HA) administration on top of the standard medical treatment (SMT) on the clinical outcomes of a subgroup of 85 outpatients with liver cirrhosis, uncomplicated ascites and insulin-treated diabetes mellitus type 2 (ITDM). Compared to patients in the SMT arm, the SMT + HA group showed a better overall survival (86% vs. 57%, p =.016) and lower incidence rates of paracenteses, overt hepatic encephalopathy, bacterial infections, renal dysfunction and electrolyte disorders. Hospital admissions did not differ between the two arms, but the number of days spent in hospital was lower in the SMT + HA group. In conclusion, in a subgroup of ITDM outpatients with decompensated cirrhosis and ascites, long-term HA administration was associated with better survival and a lower incidence of cirrhosis-related complications.

Volume: 44 Pages: 2108-2113

Keywords: ascites; bacterial infections; diabetes mellitus; hepatic encephalopathy; long-term albumin treatment; renal dysfunction; survival;

Euclid preparation XLIII. Measuring detailed galaxy morphologies for Euclid with machine learning

Authors: AREA MIN. 02 - Scienze fisiche; ASTRONOMY & ASTROPHYSICS###0004-6361; NQF-9312-2025; DWY-3410-2022; GCV-8309-2022; GBV-7145-2022; IVA-4275-2023; B-4348-2013; DWR-0706-2022; Y-9126-2019; DWO-2405-2022; Z-4828-2019; GWV-3568-2022; A-5940-2015; GBD-1861-2022; DVE-7652-2022; OVT-7176-2025; GGL-1794-2022; H-4394-2019; PCO-3236-2025; EJM-8740-2022; GBC-8404-2022; FZO-1254-2022; FYJ-9637-2022; CDR-2303-2022; C-4378-2014; O-9369-2015; GBF-1843-2022; EKV-4052-2022; DVB-2560-2022; L-8385-2017; IZS-1150-2023; M-2616-2015; AAG-7753-2020; GBO-0318-2022; E-2727-2014; FCH-5665-2022; JFJ-3489-2023; HZM-8546-2023; GBS-0220-2022; H-8587-2015; DVC-6323-2022; LTU-6502-2024; PGG-2427-2026; AGZ-3259-2022; FZL-7353-2022; A-2693-2010; PCA-2324-2025; HLX-2021-2023; HKB-2933-2023; EUO-2530-2022; EUK-3820-2022; J-3686-2012; CPC-6980-2022; AAR-6622-2021; CQF-5798-2022; KLD-3528-2024; DXA-1952-2022; ITP-9423-2023; DVG-8690-2022; GAZ-3876-2022; GBB-1832-2022; JWI-2163-2024; ABF-7029-2021; DWK-1716-2022; CTE-6775-2022; CSK-3817-2022; FBF-5584-2022; FBV-0790-2022; S-8590-2017; CTZ-4163-2022; GBH-2365-2022; EYY-4006-2022; DWQ-9372-2022; DWS-1040-2022; DXH-0671-2022; FFG-2233-2022; GEK-4486-2022; CYT-5449-2022; OOP-8239-2025; DUU-4676-2022; B-8502-2016; FKB-6410-2022; GFM-0308-2022; A-2699-2012; GAU-7672-2022; KES-2001-2024; DWC-8789-2022; DWZ-6747-2022; DFQ-7859-2022; AAH-9937-2020; DZP-0372-2022; AAX-3485-2021; D-1300-2016; FNO-5530-2022; GNG-7078-2022; FNC-4379-2022; FLD-9518-2022; AAB-4321-2020; DVP-3997-2022; FNA-5485-2022; AAW-4410-2021; DWT-4779-2022; DZP-5216-2022; FNB-0821-2022; C-3218-2017; HTJ-4919-2023; DWD-4131-2022; DLB-6897-2022; HTM-1531-2023; GBD-7573-2022; DMG-4306-2022; IVG-7504-2023; FSY-2184-2022; DMX-5934-2022; ABC-8644-2021; DNY-0415-2022; AAR-4345-2020; K-4114-2015; OON-3882-2025; DNW-6364-2022; DXL-4304-2022; GCA-5113-2022; GCT-2940-2022; DXO-8435-2022; H-1761-2016; DXM-5348-2022; GBG-9412-2022; DPD-7597-2022; IZJ-2041-2023; GBV-4959-2022; GWX-9207-2022; FZJ-5145-2022; J-5067-2012; EAA-4768-2022; JAE-9097-2023; L-8068-2014; CFK-4637-2022; DZM-7523-2022; Q-2220-2015; T-7378-2018; AAB-2503-2019; GCB-5227-2022; DYT-7473-2022; HNI-8187-2023; GCA-5567-2022; JCG-3503-2023; Q-6715-2019; ABD-6783-2021; DZU-8266-2022; EAZ-0566-2022; EIA-6036-2022; O-9396-2015; AAO-6325-2021; O-9495-2015; GDW-2905-2022; CHT-0596-2022; DTO-7937-2022; HTG-8587-2023; CMV-6954-2022; JWO-0785-2024; GBY-6621-2022; FLM-0394-2022; HUJ-7899-2023; B-8712-2017; DJO-8166-2022; LXV-7382-2024; FXS-9180-2022; JMK-1133-2023; P-2194-2018; DYK-4428-2022; ECX-7840-2022; AAH-3743-2019; DTU-2081-2022; FXV-4290-2022; CEY-5520-2022; AAZ-4907-2020; KTI-3074-2024; B-3004-2019; CIW-4665-2022; CGZ-3153-2022; EPI-1133-2022; AFR-7693-2022; O-9391-2015; KDL-3231-2024; OZD-6988-2025; S-1204-2016; GBB-5111-2022; HOH-0341-2023; CMH-0439-2022; EQT-2114-2022; PDR-7717-2025; ERD-3189-2022; CNT-5485-2022; L-6378-2014; IDQ-0489-2023; L-2472-2017; CDE-1189-2022; AAW-1061-2020; FYF-0438-2022; DUJ-9002-2022; EVC-7104-2022; CRZ-8120-2022; C-2920-2017; L-4894-2014; PDR-5897-2025; DWN-8747-2022; ABB-8257-2020; J-1632-2012; EZW-1554-2022; DSX-9005-2022; JZW-7667-2024; DWK-0332-2022; HRR-2616-2023; ITW-2356-2023; GEC-5455-2022; HRX-7202-2023; PGA-1439-2026; IZP-8032-2023; FZY-7746-2022; DWL-3001-2022; ABA-3922-2020; U-7309-2018; AAC-2261-2020; LRV-2049-2024; FMO-3603-2022; GFP-2203-2022; D-1237-2017; DVN-0580-2022; PHJ-0952-2026; AAI-1245-2021; AAN-7016-2021; DNL-3219-2022; FTV-6637-2022; ORK-4232-2025; V-1081-2019; JCV-3612-2023; GCY-0967-2022; GGM-6223-2022; GEF-7978-2022; DWT-7233-2022; FXG-6905-2022; R-3469-2017; IYS-3498-2023; GCB-1754-2022; JCM-8241-2023; JAN-6167-2023; EAO-6360-2022; LGB-5701-2024; GDF-8239-2022; CDT-0258-2022; LXA-1722-2024; JEZ-2766-2023; MVC-8981-2025; CDU-7975-2022; JSZ-6163-2023; ECF-2024-2022; A-9058-2016; IAD-4339-2023; AAW-3335-2020; 58122394000; 57193558463; 57191290632; 23050749700; 24439181000; 7003910265; 57219737156; 36237905600; 7004293616; 7005317106; 55868798300; 57219746647; 55541304900; 35494536400; 57222301390; 37068332400; 55929371000; 36238621200; 6701390827; 6701409861; 14629998500; 56176939800; 8651648800; 24482926400; 57225389323; 7102960752; 6506892241; 6602293713; 6701447926; 7004168457; 7004279376; 35117442400; 56592859600; 8316050500; 57193414472; 57090221700; 54924573500; 56260193000; 37121732700; 6507398813; 55757270100; 8856476200; 24069757200; 7004529134; 26663174300; 6603213706; 7006071419; 57212263363; 6506323808; 6601991850; 6602678698; 56181792800; 57200514857; 9639653200; 36627225700; 6506341877; 56592156500; 9535760600; 24173378000; 14630273900; 56261365400; 36657273100; 8527480900; 9270789600; 14008117700; 6603519641; 7202555066; 7006022077; 16024707000; 6603380199; 36663730200; 55539553700; 55885669700; 35227493200; 37123976000; 6701865592; 55578049300; 56216916000; 7102120605; 6603602446; 7003825248; 6603205767; 6603770482; 56403356600; 36195926600; 10239419900; 14025617800; 6506385309; 36933808800; 55779479900; 13407562800; 7102174334; 56229506700; 14056466700; 7102846243; 55665939900; 7005525798; 14832846900; 7004208543; 35299820900; 7004629002; 55668172300; 14050522100; 58095754900; 57203234808; 55913343900; 57544565000; 7003604949; 57203250534; 15770290900; 6602930238; 57190439701; 7006538931; 8842216700; 6506955003; 36490343100; 55337191500; 7402364894; 57225899623; 57190443165; 8915699600; 6603819159; 7004160690; 15129157800; 48663031800; 8833942000; 57218941481; 14063887300; 54797318800; 55845420026; 6602208520; 6602315420; 14823864100; 7005106453; 57220082325; 55414427600; 35314080800; 58937209900; 17436196900; 57203391123; 57191960842; 6701439004; 6602565951; 57191419742; 56286395400; 10244106400; 7101771030; 56273947300; 8042894900; 55595999000; 9333441800; 7004185737; 6602409206; 57189300153; 36905906400; 6603819488; 55543336500; 9244606800; 57202592808; 12809267200; 35070066100; 57815020000; 26326923900; 35216145800; 6603351766; 57219119015; 56512377200; 35194662000; 7003963996; 57203063840; 35387346400; 46461103400; 42260895600; 57220414927; 56818885600; 7006764136; 56134803400; 57225065454; 57214989073; 6602458029; 57193874792; 9337037600; 7103030457; 55948641800; 56653598400; 57219376526; 7007018277; 23485171100; 34569356300; 35072386500; 6602521535; 57199061795; 24074399500; 6701458135; 55976971800; 58696967900; 6602348000; 57218304683; 56239931500; 58073729200; 7004144883; 7003645652; 55944081300; 57206536839; 56242244500; 15131601400; 14630220200; 59076718900; 36674792500; 8833942900; 57224183772; 36966126400; 57218097629; 56153170500; 26642611400; 57213763435; 57210924350; 6508080858; 6701309093; 6603292899; 56463558800; 22951241500; 57845873200; 23393165800; 56383649900; 7101983827; 35092838400; 7006221760; 35422761600; 42262265600; 35463408300; 55194301800; 59146418100; 7101903552; 57203270249; 16031797900; 57220131178; 36495525900; 55672552800; 56881732300; 57201003368; 6506381727; 7005050491; 55435714500; 57194728774; 35417736300; 58502049600; 6603851717; 36237138500; 6701718244; 7004109829; 59800191100; 57132747000; 58483607200; 6504758580; 6506892358; 14632583100; 55158076000

Journal: ASTRONOMY & ASTROPHYSICS

Published: 2024

DOI: 10.1051/0004-6361/202449609

The Euclid mission is expected to image millions of galaxies at high resolution, providing an extensive dataset with which to study galaxy evolution. Because galaxy morphology is both a fundamental parameter and one that is hard to determine for large samples, we investigate the application of deep learning in predicting the detailed morphologies of galaxies in Euclid using Zoobot, a convolutional neural network pretrained with 450 000 galaxies from the Galaxy Zoo project. We adapted Zoobot for use with emulated Euclid images generated based on Hubble Space Telescope COSMOS images and with labels provided by volunteers in the Galaxy Zoo: Hubble project. We experimented with different numbers of galaxies and various magnitude cuts during the training process. We demonstrate that the trained Zoobot model successfully measures detailed galaxy morphology in emulated Euclid images. It effectively predicts whether a galaxy has features and identifies and characterises various features, such as spiral arms, clumps, bars, discs, and central bulges. When compared to volunteer classifications, Zoobot achieves mean vote fraction deviations of less than 12% and an accuracy of above 91% for the confident volunteer classifications across most morphology types. However, the performance varies depending on the specific morphological class. For the global classes, such as disc or smooth galaxies, the mean deviations are less than 10%, with only 1000 training galaxies necessary to reach this performance. On the other hand, for more detailed structures and complex tasks, such as detecting and counting spiral arms or clumps, the deviations are slightly higher, of namely around 12% with 60 000 galaxies used for training. In order to enhance the performance on complex morphologies, we anticipate that a larger pool of labelled galaxies is needed, which could be obtained using crowd sourcing. We estimate that, with our model, the detailed morphology of approximately 800 million galaxies of the Euclid Wide Survey could be reliably measured and that approximately 230 million of these galaxies would display features. Finally, our findings imply that the model can be effectively adapted to new morphological labels. We demonstrate this adaptability by applying Zoobot to peculiar galaxies. In summary, our trained Zoobot CNN can readily predict morphological catalogues for Euclid images.

Volume: 689

Keywords: galaxies: evolution; galaxies: structure; methods: data analysis; methods: observational; techniques: image processing;

Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients

Authors: Miglietta Federica; Pontolillo Letizia; De Angelis Carmine; Caputo Roberta; Marino Monica; Bria Emilio; Di Rienzo Rossana; Verrazzo Annarita; Buonerba Carlo; Tortora Giampaolo; Di Lorenzo Giuseppe; Del Mastro Lucia; Giuliano Mario; Montemurro Filippo; Puglisi Fabio; Guarneri Valentina; De Laurentiis Michelino; Scafuri Luca; Arpino Grazia

Journal: BREAST

Published: 2024

DOI: 10.1016/j.breast.2024.103713

Background: The last years have seen unprecedented improvement in breast cancer (BC) survival rates. However, this entirely apply to female BC patients, since gender minorities (male, transgender/gender-diverse) are neglected in BC phase III registration clinical trials. Methods: We conducted a scoping review of phase III clinical trials of agents with a current positioning within the therapeutic algorithms of BC. Results: We selected 51 phase III trials. Men enrollment was allowed in 35.3% of trials. In none of the trial inclusion/exclusion criteria referred to transgender/gender-diverse people. A numerical higher rate of enrolled men was observed in the contemporary as compared to historical group. We found a statistically significant association between the drug class and the possibility of including men: 100%, 80%, 50%, 33.3%, 25%, 10% and 9.1% of trials testing ICI/PARP-i, ADCs, PI3K/AKT/mTOR-i, anti-HER2 therapy, CDK4/6-i, ET alone, and CT alone. Overall, 77409 patients were enrolled, including 112 men (0.2%). None of the trial reported transgender/gender-diverse people proportion. Studies investigating PARP-i were significantly associated with the highest rate of enrolled men (1.42%), while the lowest rates were observed for trials of CT (0.13%), ET alone (0.10%), and CDK 4/6-I (0.08%), p < 0.001. Conclusions: We confirmed that gender minorities are severely underrepresented among BC registration trials. We observed a lower rate of men in trials envisaging endocrine manipulation or in less contemporary trials. This work sought to urge the scientific community to increase the awareness level towards the issue of gender minorities and to endorse more inclusive criteria in clinical trials.

Volume: 75

Keywords: Breast cancer; Gender diversity; Gender minorities; Male; Transgender and gender diverse people;

Electrophysiological Screening to Assess Foot Drop Syndrome in Severe Acquired Brain Injury in Rehabilitative Settings

Authors: Piccione Francesco; Cerasa Antonio; Tonin Paolo; Carozzo Simone; Calabro Rocco Salvatore; Masiero Stefano; Lucca Lucia Francesca; Calabrò Rocco Salvatore

Journal: BIOMEDICINES

Published: 2024

DOI: 10.3390/biomedicines12040878

Background: Foot drop syndrome (FDS), characterized by severe weakness and atrophy of the dorsiflexion muscles of the feet, is commonly found in patients with severe acquired brain injury (ABI). If the syndrome is unilateral, the cause is often a peroneal neuropathy (PN), due to compression of the nervous trunk on the neck of the fibula at the knee level; less frequently, the cause is a previous or concomitant lumbar radiculopathy. Bilateral syndromes are caused by polyneuropathies and myopathies. Central causes, due to brain or spinal injury, mimic this syndrome but are usually accompanied by other symptoms, such as spasticity. Critical illness polyneuropathy (CIP) and myopathy (CIM), isolated or in combination (critical illness polyneuromyopathy, CIPNM), have been shown to constitute an important cause of FDS in patients with ABI. Assessing the causes of FDS in the intensive rehabilitation unit (IRU) has several limitations, which include the complexity of the electrophysiological tests, limited availability of neurophysiology consultants, and the severe disturbance in consciousness and lack of cooperation from patients. Objectives: We sought to propose a simplified electrophysiological screening that identifies FDS causes, particularly PN and CIPNM, to help clinicians to recognize the significant clinical predictors of poor outcomes in severe ABI at admission to IRU. Methods: This prospective, single-center study included 20 severe ABI patients with FDS (11 females/9 males, mean age 55.10 + 16.26; CRS-R= 11.90 + 6.32; LCF: 3.30 + 1.30; DRS: 21.45 + 3.33), with prolonged rehabilitation treatment (≥2 months). We applied direct tibialis anterior muscle stimulation (DMS) associated with peroneal nerve motor conduction evaluation, across the fibular head (NCS), to identify CIP and/or CIM and to exclude demyelinating or compressive unilateral PN. Results: At admission to IRU, simplified electrophysiological screening reported four unilateral PN, four CIP and six CIM with a CIPNM overall prevalence estimate of about 50%. After 2 months, the CIPNM group showed significantly poorer outcomes compared to other ABI patients without CIPNM, as demonstrated by the lower probability of achieving endotracheal-tube weaning (20% versus 90%) and lower CRS-R and DRS scores. Due to the subacute rehabilitation setting of our study, it was not possible to evaluate the motor results of recovery of the standing position, functional walking and balance, impaired by the presence of unilateral PN. Conclusions: The implementation of the proposed simplified electrophysiological screening may enable the early identification of unilateral PN or CIPNM in severe ABI patients, thereby contributing to better functional prognosis in rehabilitative settings.

Volume: 12

Keywords: acquired brain injury; critical illness myopathy; critical illness polyneuropathy; electrophysiological screening; rehabilitation outcomes;

Nonlinear Model Predictive Control of a BMI-Guided Wheelchair for Navigation in Unknown Environments

Authors: De Lazzari Davide; Simonetto Piero; Threat Niccolo; Tonin Luca; Carli Ruggero; Turcato Niccolò

Journal: 2024 EUROPEAN CONTROL CONFERENCE, ECC 2024

Published: 2024

DOI: 10.23919/ECC64448.2024.10591234

The ability to discern human intentions from brain signals has opened the possibility of leveraging Brain-Machine Interfaces (BMIs) for the control of robotic devices, especially benefiting individuals with severe motor disabilities. In this work, we present a novel approach for navigating a semiautonomous wheelchair towards targets generated by a BMI, all while ensuring collision avoidance. Our approach employs Nonlinear Model Predictive Control (NMPC) for real-time trajectory generation in unknown and dynamic environments. The empirical results obtained from real-world experiments clearly demonstrate the advancements of our solution over current state-of-the-art techniques. Our implementation is proven to outperform well-established methods in terms of both smoothness and alignment with the user’s intended behavior.

Pages: 3582-3587

Decoding EEG Signals During the Observation of Robotic Arm Movements

Authors: Cimarosto Pietro; Kostoglou Kyriaki; Tonin Luca; Mueller-Putz Gernot; Muller-Putz Gernot

Journal: IEEE ACCESS

Published: 2024

DOI: 10.1109/ACCESS.2024.3519699

Recent studies in the domain of invasive brain-computer interfaces (BCIs) have revealed that neural activity recorded during the observation of robotic movements in a reach-and-grasp task carries information that can be utilized to improve the active online decoding of motor intention. In the non-invasive domain, the spectral characteristics of human brain activity during the observation of robotic movements has been widely investigated. However, focusing only on the frequency components of electroencephalography (EEG) for motor control decoding is a poorly suitable strategy due to its scarce temporal resolution. Following a different approach, we explored temporal features of EEG filtered in the delta band (Low-Frequency EEG, or LF-EEG) for the continuous decoding of control-oriented kinematic trajectories. We designed an experimental paradigm aimed at investigating how the observation of center-out target-oriented reaching movements executed by a robotic arm in the 2D plane is encoded in low-frequency EEG signals. By employing machine learning algorithms and novel approaches, we were able to continuously decode the LF-EEG into movement trajectories, achieving performance significantly above chance-level. This confirms that low-frequency neural activity measured non-invasively during a movement observation task contains adequate amounts of movement-related information for BCI applications.

Volume: 12 Pages: 195731-195744

Keywords: Brain-computer interfaces; electroencephalography; movement observation; observation-based calibration; robotic arm;

Optimization and evaluation of the control framework for brain-machine interfaces

Authors: Forin Paolo; Beraldo Gloria; Tortora Stefano; Tonin Luca

Journal: 2024 IEEE 20TH INTERNATIONAL CONFERENCE ON AUTOMATION SCIENCE AND ENGINEERING, CASE 2024

Published: 2024

DOI: 10.1109/CASE59546.2024.10711648

This work presents and evaluates a method for reducing the number of hyper-parameters in the continuous control system used by a 2-class motor imagery (MI) brain-machine interface (BMI). The work focuses on two parameters (ω and ψ) used within a dynamical control system that considers the nature and temporal evolution of the BMI decoder output and that it has been already validated in the past.To identify the optimal values for the parameters, we analysed a dataset of 12 subjects performing 2-class MI tasks. For each subject, we defined a new metric to investigate the existence of a relationship between the hyper-parameters. The study reveals a quadratic relationship with coefficient of determination (R2) of 81.67%.Finally, the established relationship was evaluated through an closed-loop experiment involving three healthy subjects. Results demonstrated the potential use of the discovered quadratic relationship to reduce the number of parameters for the dynamical control system and, thus, to simplify the BMI operations.

Pages: 1313-1318